BridgeBio Pharma, Inc. (BBIO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 15.09B |
| Enterprise Value | 17.25B |
| P/E Ratio | -18.25 |
| PEG Ratio | -1.42 |
| Price/Sales Ratio | 17.95 |
| Price/Book Ratio | -5.09 |
| Enterprise/Revenue | 20.5 |
| Enterprise/EBITDA | -23.91 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.98 |
| Operating Margin | -0.76 |
AD
Management Effectiveness
| Return On Assets | -0.57 |
| Return On Equity | 0.32 |
Income Statement
| Revenue | 502.08M |
| Revenue/Share | 3.64 |
| Gross Profit | 473.81M |
| EBITDA | -676.45M |
| Net Income | -729.31M |
| Diluted EPS | -3.79 |
Balance Sheet
| Total Cash | 720.16M |
| Total Cash/Share | 3.68 |
| Total Debt | 2.49B |
| Total Debt/Equity | -0.99 |
| Current Ratio | 1.23 |
| Book Value Per Share | -12.8 |
Price History
| 52-Week Change | 16.78 |
| 52-Week High | 93.42 |
| 52-Week Low | 52.75 |
| Moving Average 50 Days | 74.53 |
| Moving Average 200 Days | 73.34 |
Statistics
| Average Volume | 2.41M |
| Shares Outstanding | 195.86M |
| % Held by Institutions | 100.29 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
